HAE Haemonetics Corporation
Healthcare$66.57+0.00%OpenMarket Cap: $3.03B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$75.33
Target (Median)
$70.00
Target Range
$67.00 - $89.00
Upside from current price: 13.2%
Rating Distribution
4 Strong Buy4 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-22 | B of A Securities | upgrade | Buy | Neutral |
| 2026-05-12 | Barrington Research | maintain | Outperform | Outperform |
| 2026-05-08 | JP Morgan | maintain | Neutral | Neutral |
| 2026-04-13 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-11 | Citigroup | maintain | Neutral | Neutral |
| 2026-02-06 | Barrington Research | maintain | Outperform | Outperform |
| 2026-02-06 | Citigroup | maintain | Neutral | Neutral |
| 2026-02-06 | Mizuho | maintain | Outperform | Outperform |
| 2026-02-06 | BTIG | maintain | Buy | Buy |
| 2025-12-17 | Mizuho | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Sun Mar 28 | $5.22 | $1.40B | 7 |
| Mon Mar 29 | $5.29 | $1.39B | 8 |
| Tue Mar 28 | $5.77 | $1.47B | 7 |
| Wed Mar 29 | $5.91 | $1.48B | 5 |